As of 2/12/2020 to date, vaccine stocks (MRNA,BNTX,NVAX,AZN,VIR,ARCT,INO,TBIO,VXRT) had a 233% outperformance against FAANG technology stocks (FB,AMZN,AAPL,NFLX,GOOG).
This trend of outperformance is likely to continue in the coming period because valuations of tech stocks need to be held at reasonable levels to avoid a sharp collapse of NASDAQ one day. On the other hand, the stock prices of vaccines have to integrate in advance the forecasts of vaccine demand for several more years (unfortunately), as well as the development of new treatments in all kinds of diseases with new methods of Biotechnology (mRNA, DNA, Gene editing etc.).
Below are presented the mid-term trend charts of Vaccine and FAANG stocks.
Notice that the Vaccine stocks trend is upward (in both RSI and MACD) while the FAANG stocks trend is downward.
Disclaimer The writer of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.